Testing effectiveness (Phase 2)Study completedNCT01027351
What this trial is testing
Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
Who this might be right for
Meningococcal Disease
Novartis Vaccines 163